SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to a significant stock drop following mixed results from a Phase 3 trial for their skin disease drug, sonelokimab. The community is actively discussing whether the sell-off is an overreaction, with some citing the company's strong cash position and potential for a buyout, while others focus on the trial's shortcomings and competitive landscape. Traders are weighing potential bounce opportunities against the risk of further decline in this volatile biotech stock.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp is trending as it reported adjusted EPS and revenue exceeding consensus estimates, along with raising its FY25 adjusted EPS view. Community members are discussing the surprisingly strong numbers and potential for further gains, while others are wary of typical post-earnings fades. The positive results offer optimism in the cruise line sector's continued recovery.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Dogwood Therapeutics Inc.

Dogwood Therapeutics is trending due to a recent licensing agreement for a cancer-related pain treatment, sparking community excitement.  Traders are highlighting its low float and potential for a significant upward move, drawing comparisons to other stocks with similar setups. Optimism surrounds upcoming catalysts and the possibility of a substantial price increase.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to concerns about increased competition from a potential merger between Paramount Skydance and Warner Bros. Discovery, impacting its position in the streaming market. Community members are weighing the potential effects on content and market share, while also considering Netflix's upcoming live sports events like the Canelo fight as a possible catalyst for subscriber growth and revenue diversification through advertising.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members rally around the token's mission to champion cannabis culture and foster a sense of freedom and community. The coin is seen as more than just a digital asset, but as a symbol of a lifestyle. Recent discussion points include its potential within the broader cannabis industry and support from public figures.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending after multiple analysts raised their price targets, citing the upcoming launch of its non-gaming self-serve tool and potential growth in ad revenue. The community is debating whether the stock is in bubble territory, while some traders are attempting to time pullbacks and short the stock, others suggest the stock may be influenced by news regarding TikTok. Bullish sentiment remains strong overall, as the stock approaches new all-time highs, with some anticipating further price target increases.

WiMi Hologram Cloud, Inc. engages in the provision of holographic services and products. It offers comprehensive solutions including AR automotive HUD software, 3D holographic pulse LiDAR, head-mounted light field equipment, holographic semiconductors, cloud software, and car navigation systems. Its services and holographic AR technologies include holographic AR automotive application, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, interactive holographic communication and other holographic AR technologies. The firm operates through the following segments: AR Advertising Services, AR Entertainment, and Semiconductor Business. The AR Advertising Services segment enables the integration of real or animated 3D objects into video footage, creating seamless and interactive visual experiences. The AR Entertainment segment focuses on payment middleware software, game distribution platforms, and holographic MR software. The Semiconductor Business segment provides central processing algorithm services, computer chip products, and comprehensive solutions integrating software and hardware for enterprise customers. The company was founded by Jie Zhao in May 2015 and is headquartered in Chaoyang, China.

Wimi Hologram Cloud Inc - Ordinary Shares - Class B

Wimi Hologram Cloud Inc - ADR

WIMI is trending as investors discuss the company's recent net income growth and significant cash reserves, leading to debates about its valuation. Community members are weighing the potential for a squeeze against concerns about the company's business practices and past performance, particularly in relation to other related stocks. The conversation includes the company's involvement in AI, quantum computing, and holographic technology.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

GTBIF is trending as cannabis stocks react to potential rescheduling catalysts, fueled by endorsements and discussions within the community. Community members are weighing the potential benefits of rescheduling, such as tax relief and advantages over Canadian companies, while others express skepticism, citing political hurdles and past disappointments. Some investors highlight GTBIF's strong financials and potential for growth, while emphasizing the importance of value investing in the cannabis sector.

Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA.

Electronic Arts, Inc.

Electronic Arts is trending amid reports of a potential $50 billion buyout, which could be the largest leveraged buyout in history, with shareholders possibly receiving $210 per share. The gaming community is discussing the implications of a private equity firm and Saudi Arabia's Public Investment Fund acquiring the company, including potential changes to game development and content. Some traders are taking profits at the current level, while others anticipate further upside as the stock price has not yet reached the rumored buyout price.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending amid discussions about its strength as a safe-haven asset and potential for further gains, with some community members citing dollar weakness and central bank activity as bullish catalysts. Some traders believe GLD is overbought and due for a correction, while others remain confident in its upward trajectory, particularly in light of economic uncertainty and potential rate cuts. Community members are actively debating entry and exit points, with a few expressing concerns about a possible bubble.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin Oramed Announces Transformative Joint Venture to Accelerate Development and...

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt PR Newswire NEW YORK, Oct. 7, 2024 NEW...

Oramed Letter to Shareholders

Oramed Letter to Shareholders Oramed Letter to Shareholders PR Newswire NEW YORK, June 26, 2024 Stock Repurchase Program Scilex Senior Secured NotePhase 3 Oral Insulin Trial in USJV with Chinese...

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock PR Newswire NEW YORK, June 26, 2024 NEW YORK, June 26...

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex ), an innovative revenue-generating company focused on acquiring, developing and commercializing...

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...

Oramed Pharmaceuticals (ORMP, $3.24) Aroon Indicator entered an Uptrend on March 04, 2024.

Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Oramed Pharmaceuticals (ORMP, $3.43) Aroon Indicator entered an Uptrend on March 01, 2024.

Oramed Pharmaceuticals (ORMP, $3.28) Aroon Indicator entered an Uptrend on February 29, 2024.

Oramed Pharmaceuticals (ORMP, $3.41) RSI Indicator left the overbought zone on February 28, 2024

This is a signal that ORMP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Oramed Pharmaceuticals, Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

ORMP
Oramed Pharmaceuticals, Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORMP News

ORMP Oramed Pharmaceuticals, Inc